US OptionsDetailed Quotes
HIMS241011C17500
- 0.70
- +0.05+7.69%
15min DelayClose Oct 4 16:00 ET
0.75High0.35Low
0.65Open0.65Pre Close323 Volume474 Open Interest17.50Strike Price19.12KTurnover79.39%IV3.06%PremiumOct 11, 2024Expiry Date0.16Intrinsic Value100Multiplier4DDays to Expiry0.54Extrinsic Value100Contract SizeAmericanOptions Type0.5615Delta0.2560Gamma25.23Leverage Ratio-0.0746Theta0.0011Rho14.16Eff Leverage0.0076Vega
Hims & Hers Health Stock Discussion
nailed it
Their obesity drug is not affected by the side effects discovered by Novo Nordisk.
Novo's drug is CB1 receptor based
HIMS' is manufactured by Nivagen and is a GLP-1 injection.
Gapping up
$NVIDIA (NVDA.US)$ shares were set to rise on Thursday as investors processed the news of the chipmaker's investment in ChatGPT creator, OpenAI. Shares rose 1.4% in premarket.
$Wolfspeed (WOLF.US)$, a silicon carbide technology company, was downgraded by Mizuho from Neutral to Underperform, with the price target lowered from $17 to $8. The stock dropped 5.25% to $8.67.
Gapping down
$Tesla (TSLA.US)$ dropp...
$Cloudflare (NET.US)$ $Hims & Hers Health (HIMS.US)$ $DocuSign (DOCU.US)$ $Invesco QQQ Trust (QQQ.US)$
No comment yet